Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brosnan, C. F.
Right arrow Articles by Raine, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brosnan, C. F.
Right arrow Articles by Raine, C. S.

Neurology, Vol 45, Issue 6 S16-S21, Copyright © 1995 by American Academy of Neurology

VIEWS & REVIEWS

Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species

CF Brosnan, B Cannella, L Battistini and CS Raine
Department of Pathology, Neurology and Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

The relative levels and cellular distribution of proinflammatory and regulatory cytokines have been examined by immunohistochemistry in multiple sclerosis (MS) lesions of differing activity and compared with CNS tissue from other neurologic diseases with an inflammatory or noninflammatory component. Results show widespread distribution of cytokines in association with both perivascular inflammatory cells and glial cells in all types of inflammatory lesions. Although no obvious pattern of proinflammatory versus regulatory cytokines could be determined in MS lesions, proinflammatory cytokines were rarely noted in normal and noninflammatory conditions, whereas regulatory cytokines were readily detectable in the same diseases. The possible relevance of these cytokine patterns to adhesion molecule expression and the presence of reactive nitrogen species is also addressed.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. T. Argaw, Y. Zhang, B. J. Snyder, M.-L. Zhao, N. Kopp, S. C. Lee, C. S. Raine, C. F. Brosnan, and G. R. John
IL-1beta Regulates Blood-Brain Barrier Permeability via Reactivation of the Hypoxia-Angiogenesis Program
J. Immunol., October 15, 2006; 177(8): 5574 - 5584.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. M. Curran, B. D. Griffin, D. O'Toole, K. J. Brady, S. N. Fitzgerald, and P. N. Moynagh
The Synthetic Cannabinoid R(+)WIN 55,212-2 Inhibits the Interleukin-1 Signaling Pathway in Human Astrocytes in a Cannabinoid Receptor-independent Manner
J. Biol. Chem., October 28, 2005; 280(43): 35797 - 35806.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Abromson-Leeman, R. Bronson, Y. Luo, M. Berman, R. Leeman, J. Leeman, and M. Dorf
T-Cell Properties Determine Disease Site, Clinical Presentation, and Cellular Pathology of Experimental Autoimmune Encephalomyelitis
Am. J. Pathol., November 1, 2004; 165(5): 1519 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
T. Hooper-van Veen, H. M Schrijver, A. Zwiers, J B. A Crusius, D. L Knol, N. F Kalkers, M. L Laine, F. Barkhof, A S. Pena, C. H Polman, et al.
The interleukin-1 gene family in multiple sclerosis susceptibility and disease course
Multiple Sclerosis, December 1, 2003; 9(6): 535 - 539.
[Abstract] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
I. HUITINGA, Z. A. ERKUT, D. VAN BEURDEN, and D. F. SWAAB
The Hypothalamo-Pituitary-Adrenal Axis in Multiple Sclerosis
Ann. N.Y. Acad. Sci., May 1, 2003; 992(1): 118 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
Z A Erkut, E Endert, I Huitinga, and D F Swaab
Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis
Multiple Sclerosis, June 1, 2002; 8(3): 229 - 236.
[Abstract] [PDF]

Home page
 Mult SclerHome page
L P Weiner, N J Kachuck, W Gilmore, and B Lund
Immunological aspects of secondary progressive multiple sclerosis
Multiple Sclerosis, February 1, 2002; 8(1): 83 - 84.
[PDF]

Home page
 J. Immunol.Home page
A. Willuweit, G. Sass, A. Schoneberg, U. Eisel, G. Tiegs, and M. Clauss
Chronic Inflammation and Protection from Acute Hepatitis in Transgenic Mice Expressing TNF in Endothelial Cells
J. Immunol., October 1, 2001; 167(7): 3944 - 3952.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Clauss, C. Sunderkotter, B. Sveinbjornsson, S. Hippenstiel, A. Willuweit, M. Marino, E. Haas, R. Seljelid, P. Scheurich, N. Suttorp, et al.
A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability
Blood, March 1, 2001; 97(5): 1321 - 1329.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. J. Lee, K. Drabik, N. J. Van Wagoner, S. Lee, C. Choi, Y. Dong, and E. N. Benveniste
ICAM-1-Induced Expression of Proinflammatory Cytokines in Astrocytes: Involvement of Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Pathways
J. Immunol., October 15, 2000; 165(8): 4658 - 4666.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
C. FERRI, F. L. SCIACCA, L. M. E. GRIMALDI, F. VEGLIA, G. MAGNANI, G. SANTUCCIO, G. COMI, N. CANAL, and L. M. E. GRIMALDI
Lack of association between IL-1A and IL-1B promoter polymorphisms and multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, October 1, 2000; 69(4): 564 - 565.
[Full Text]

Home page
 Mult SclerHome page
B L Bartnik, B H. Juurlink, and R M Devon
Macrophages: their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress
Multiple Sclerosis, February 1, 2000; 6(1): 37 - 42.
[Abstract] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
R Furlan, M Filippi, A Bergami, M A Rocca, V Martinelli, P L Poliani, L M E Grimaldi, G Desina, G Comi, and G Martino
Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study
J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 785 - 788.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Dowling, X. Ming, S. Raval, W. Husar, P. Casaccia-Bonnefil, M. Chao, S. Cook, and B. Blumberg
Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques
Neurology, November 1, 1999; 53(8): 1676 - 1676.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
D. Freyer, R. Manz, A. Ziegenhorn, M. Weih, K. Angstwurm, W.-D. Docke, A. Meisel, R. R. Schumann, G. Schonfelder, U. Dirnagl, et al.
Cerebral Endothelial Cells Release TNF-{alpha} After Stimulation with Cell Walls of Streptococcus pneumoniae and Regulate Inducible Nitric Oxide Synthase and ICAM-1 Expression Via Autocrine Loops
J. Immunol., October 15, 1999; 163(8): 4308 - 4314.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Furlan, G. Martino, F. Galbiati, P. L. Poliani, S. Smiroldo, A. Bergami, G. Desina, G. Comi, R. Flavell, M. S. Su, et al.
Caspase-1 Regulates the Inflammatory Process Leading to Autoimmune Demyelination
J. Immunol., September 1, 1999; 163(5): 2403 - 2409.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
H. M. Schrijver, J. B. A. Crusius, B. M. J. Uitdehaag, M. A. Garcia Gonzalez, P. J. Kostense, C. H. Polman, and A. S. Pena
Association of interleukin-1{beta} and interleukin-1 receptor antagonist genes with disease severity in MS
Neurology, February 1, 1999; 52(3): 595 - 595.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J.-W. Oh, N. J. Van Wagoner, S. Rose-John, and E. N. Benveniste
Role of IL-6 and the Soluble IL-6 Receptor in Inhibition of VCAM-1 Gene Expression
J. Immunol., November 1, 1998; 161(9): 4992 - 4999.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M K Sharief
Cytokines in multiple sclerosis: pro-inflammation or pro-remyelination?
Multiple Sclerosis, June 1, 1998; 4(3): 169 - 173.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
J. A. Martiney, A. J. Rajan, P. C. Charles, A. Cerami, P. C. Ulrich, S. Macphail, K. J. Tracey, and C. F. Brosnan
Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by CNI-1493, a Macrophage-Deactivating Agent
J. Immunol., June 1, 1998; 160(11): 5588 - 5595.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
T. L. Vollmer
Multiple Sclerosis: New Approaches to Immunotherapy
Neuroscientist, March 1, 1996; 2(2): 127 - 136.
[Abstract] [PDF]

Home page
 Neurorehabil Neural RepairHome page
P.K. Coyle, L.B. Krupp, C. Doscher, Zhidian Deng, and A. Milazzo
Clinical and Immunological Effects of Cooling in Multiple Sclerosis
Neurorehabil Neural Repair, January 1, 1996; 10(1): 9 - 15.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.